Lyme IgM Line Blot Interp.

Negative

If your Lyme IgM Line Blot Interpretation (Interp.) is negative on a Lyme, Line Blot, Serum test, it means that there is no evidence of IgM antibodies specific to Lyme disease detected in your blood sample. This result suggests that you do not currently have an active or recent infection with Lyme disease. IgM antibodies are typically produced by the immune system in response to a recent infection. It's important to note that Lyme disease diagnosis often involves a two-tier testing process, which includes an initial screening test (like the IgM Line Blot) followed by a confirmatory test. A negative IgM Line Blot result may indicate that further testing is not needed if you are not exhibiting symptoms consistent with Lyme disease or if your symptoms have lasted for more than 30 days, as IgM antibodies may decline over time. However, the interpretation of Lyme disease tests should be done in consultation with a healthcare provider who can consider your symptoms, medical history, and other factors to make an accurate diagnosis or determine if additional testing is necessary.

Positive

If your Lyme IgM Line Blot Interpretation (Interp.) is positive on a Lyme, Line Blot, Serum test, it indicates the presence of IgM antibodies specific to Lyme disease in your blood sample. This positive result suggests that your immune system has produced IgM antibodies in response to an infection with the bacterium Borrelia burgdorferi, which causes Lyme disease. A positive IgM Line Blot Interp. result typically indicates an early or active infection with Lyme disease. IgM antibodies are usually produced during the initial stages of the infection, within a few weeks after exposure to the bacteria. This result suggests that you may have been recently exposed to Lyme disease or are currently experiencing an active infection. It's important to note that a positive IgM result alone may not be sufficient for a definitive diagnosis of Lyme disease. Healthcare providers often consider clinical symptoms, medical history, and may perform additional tests to confirm the diagnosis and determine the appropriate treatment.

The Lyme IgM Line Blot Interpretation (Interp.) marker is a diagnostic test marker used to assess the presence of specific antibodies called IgM antibodies in a patient's blood.

The IgM Line Blot Interp. marker helps in the diagnosis of Lyme disease by detecting IgM antibodies produced by the immune system in response to an infection with the bacterium Borrelia burgdorferi, which is the causative agent of Lyme disease. IgM antibodies are typically produced during the early stages of infection, usually within a few weeks after exposure to the bacteria.

A positive result for the IgM Line Blot Interp. marker suggests the presence of IgM antibodies against Borrelia burgdorferi, indicating a recent or active infection with Lyme disease. On the other hand, a negative result means that no IgM antibodies specific to Lyme disease were detected, suggesting the absence of an active or recent infection.

It's important to note that the interpretation of this marker should be done by a healthcare provider in conjunction with other clinical information and tests to make an accurate diagnosis of Lyme disease.

Lyme IgM Line Blot Interp.
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Lyme IgM Line Blot Interp. — 10,000+ markers explained
One Lyme IgM Line Blot Interp. result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro